Cargando…
Clinical cure and liver fibrosis reversal after postoperative antiviral combination therapy in hepatitis B-associated non-cirrhotic hepatocellular carcinoma: A case report
BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is high in China, and approximately 15%-20% of HCC cases occur in the absence of cirrhosis. Compared with patients with cirrhotic HCC, those with non-cirrhotic HCC have longer postoperative tumor-free survival. However, the overall survival...
Autores principales: | Yu, Xue-Ping, Lin, Qi, Huang, Zhi-Peng, Chen, Wei-Shan, Zheng, Ming-Hui, Zheng, Yi-Juan, Li, Ju-Lan, Su, Zhi-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829728/ https://www.ncbi.nlm.nih.gov/pubmed/33553413 http://dx.doi.org/10.12998/wjcc.v9.i3.714 |
Ejemplares similares
-
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
por: Oh, Joo Hyun, et al.
Publicado: (2023) -
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
por: Aleman, Soo
Publicado: (2016) -
Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
por: Owusu Sekyere, Solomon, et al.
Publicado: (2021) -
Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients
por: Osman, Mahmoud A, et al.
Publicado: (2016) -
De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents
por: Kuftinec, Gabriela, et al.
Publicado: (2018)